Response to letter re: Ki-67 index after neoadjuvant endocrine therapy as a prognostic biomarker in patients with ER-positive/HER2-negative early breast cancer: a systematic review and meta-analysis.

Auteurs

Martins-Branco D, Nader-Marta G, Molinelli C, Ameye L, de Azambuja E

  • Date de publication

    July 2024

  • Type

    Letter

  • Review

    Eur J Cancer

  • Researcher's name

    DE AZAMBUJA EVANDRO

  • Hôpital

    Institut Jules Bordet

  • Service

    Médecine Oncologique

  • PMID

    38996796

  • DOI

    10.1016/j.ejca.2024.114195